Why BioNTech Stock Jumped Today
_0.png?locale=de){kind=logo}
Shares of BioNTech (NASDAQ: BNTX) closed Monday's trading session 8.6% higher, lifted largely by two developments.
First, on Monday, BioNTech announced a collaboration with Crescendo Biologics to develop immunotherapies for treating cancer and other diseases. And second, Pfizer (NYSE: PFE) CEO Albert Bourla said in an interview on CNBC that a new version of its COVID-19 vaccine that is designed to target the omicron variant would be ready by March. Pfizer and BioNTech are again working together to develop the omicron-specific vaccine.
Image source: Getty Images.
Source Fool.com
